The selection of pharmacotherapy for patients with allergic rhinitis aims to control the
disease and depends on many factors. Grading of Recommendations Assessment …

Asthma, rhinitis, and atopic dermatitis (AD) are interrelated clinical phenotypes that partly
overlap in the human interactome. The concept of “one‐airway‐one‐disease,” coined over …

Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled
allergens and is one of the most common chronic conditions globally. AR often co-occurs …

One hundred and ten years after Noon's first clinical report of the subcutaneous application
of allergen extracts, allergen immunotherapy (AIT) has evolved as the most important pillar …

Introduction In allergic asthma patients, one of the more common phenotypes might benefit
from allergen immunotherapy (AIT) as add‐on intervention to pharmacological treatment …

Digital anamorphosis is used to define a distorted image of health and care that may be
viewed correctly using digital tools and strategies. MASK digital anamorphosis represents …

Background Although there are many asymptomatic patients, one of the problems of COVID‐
19 is early recognition of the disease. COVID‐19 symptoms are polymorphic and may …

Background MASK‐air® is an app that supports allergic rhinitis patients in disease control.
Users register daily allergy symptoms and their impact on activities using visual analog …

MASK‐air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled
large observational implementation studies in over 58,000 people with allergic rhinitis …

Background Co‐medication is common among patients with allergic rhinitis (AR), but its
dimension and patterns are unknown. This is particularly relevant since AR is understood …